Back to search

Article

Identifying Reasons for ACEI/ARB Non-Use in CKD Using Scalable Clinical NLP with Schema-Guided LLM Augmentation

2026-02-12

Abstract excerpt

<h4>IMPORTANCE</h4> Although angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are recommended for people with chronic kidney disease (CKD), they remain underused. Barriers to adherence, such as adverse effects or patient refusal, are frequently embedded within unstructured clinical narratives and are therefore inaccessible to structured data analytics. Scalable natural lan...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d50010b0-388b-5c54-8ee1-0834ad27becc
DOI
10.64898/2026.02.10.26346025
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Identifying Reasons for ACEI/ARB Non-Use in CKD Using Scalable Clinical NLP with Schema-Guided LLM AugmentationDOI 10.64898/2026.02.10.26346025
Select a neighboring publication to make it the new centre.